CCNE1 and neoplasm: Cyclin E overexpression was reported to be an indicator of poor outcome in several tumours, including lung cancer (Muller-Tidow et al, 2001), non-Hodgkin's lymphoma (Ferreri et al, 2001), and breast cancer (Keyomarsi et al, 2002).